Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Hatz

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Frontiers in Medicine|September 20, 2021
External Limiting Membrane Disruption Predicts Long-Term Outcome in Strict Treat-And-Extend Regimen in Neovascular Age-Related Macular DegenerationLaura Hoffmann, Katja Hatz
Acta Ophthalmologica|March 25, 2016
Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month studyKatja Hatz, Christian Prünte
The British Journal of Ophthalmology|January 13, 2016
Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degenerationKatja Hatz, Christian Prünte
Ophthalmology and Therapy|March 15, 2026
Lower Rates of Intraocular Inflammation with Aflibercept 8 mg Delivered via Pre-Filled Syringe Versus VialLaura Hoffmann, Katja Hatz
Therapeutische Umschau. Revue Therapeutique|March 17, 2016
[Retinal vein occlusion: an interdisciplinary approach]Katja Hatz, Maria Martinez
Retina (Philadelphia, Pa.)|September 23, 2016
INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB: A Treat-and-Extend TrialKatja Hatz, Christian Prünte
The British Journal of Ophthalmology|November 20, 2013
Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab responseKatja Hatz, Christian Prünte
Klinische Monatsblatter Fur Augenheilkunde|March 14, 2024
Long-term Follow-Up and Regeneration of Retinal Pigment Epithelium (RPE) after Tears of the Epithelium in Exudative Age-Related Macular Degeneration (AMD)Nicolas Skalicky, Katja Hatz-Wurziger
Frontiers in Medicine|January 26, 2023
Peripapillary and macular microvasculature in neovascular age-related macular degeneration in long-term and recently started anti-VEGF therapy versus healthy controlsCengiz Türksever, Laura Hoffmann, Katja Hatz
Ophthalmic Research|May 26, 2023
Geographic Atrophy in AMD: Prognostic Factors Based on Long-Term Follow-UpLuca Cedro, Laura Hoffmann, Katja Hatz
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Frontiers in Medicine|September 20, 2021
External Limiting Membrane Disruption Predicts Long-Term Outcome in Strict Treat-And-Extend Regimen in Neovascular Age-Related Macular DegenerationLaura Hoffmann, Katja Hatz
Acta Ophthalmologica|March 25, 2016
Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month studyKatja Hatz, Christian Prünte
The British Journal of Ophthalmology|January 13, 2016
Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degenerationKatja Hatz, Christian Prünte
Ophthalmology and Therapy|March 15, 2026
Lower Rates of Intraocular Inflammation with Aflibercept 8 mg Delivered via Pre-Filled Syringe Versus VialLaura Hoffmann, Katja Hatz
Therapeutische Umschau. Revue Therapeutique|March 17, 2016
[Retinal vein occlusion: an interdisciplinary approach]Katja Hatz, Maria Martinez
Retina (Philadelphia, Pa.)|September 23, 2016
INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB: A Treat-and-Extend TrialKatja Hatz, Christian Prünte
The British Journal of Ophthalmology|November 20, 2013
Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab responseKatja Hatz, Christian Prünte
Klinische Monatsblatter Fur Augenheilkunde|March 14, 2024
Long-term Follow-Up and Regeneration of Retinal Pigment Epithelium (RPE) after Tears of the Epithelium in Exudative Age-Related Macular Degeneration (AMD)Nicolas Skalicky, Katja Hatz-Wurziger
Frontiers in Medicine|January 26, 2023
Peripapillary and macular microvasculature in neovascular age-related macular degeneration in long-term and recently started anti-VEGF therapy versus healthy controlsCengiz Türksever, Laura Hoffmann, Katja Hatz
Ophthalmic Research|May 26, 2023
Geographic Atrophy in AMD: Prognostic Factors Based on Long-Term Follow-UpLuca Cedro, Laura Hoffmann, Katja Hatz
Pageof 5